Evaluation of Ocular Biometry in PACD With Two Swept Source Optical Coherence Tomography Devices
1 other identifier
observational
45
1 country
1
Brief Summary
Purpose: To investigate agreement between 2 swept source OCT biometers, IOL M.aster700 and Anterion, in various ocular biometry and intraocular lens (IOL) calculations of primary angle-closure disease (PACD). Methods: This was a prospective study conducted in a tertiary eye care centre involving biometric measurements obtained with 2 devices in phakic eye with diagnosis of PACD. Mean difference and intraclass correlation coefficient (ICC) with confidence limits were assessed, and calculations of estimated residual refraction of the IOL were analysed using Barrett's formula.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedFirst Submitted
Initial submission to the registry
September 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2021
CompletedFirst Posted
Study publicly available on registry
September 22, 2021
CompletedSeptember 22, 2021
September 1, 2021
1.3 years
September 3, 2021
September 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intraclass correlation coefficient of IOL power calculation
agreement between 2 swept source OCT biometers, IOL Master700 and Anterion, in intraocular lens (IOL) calculations
30 minutes per person
Intraclass correlation coefficient of various ocular biometry
agreement between 2 swept source OCT biometers, IOL Master700 and Anterion, in various ocular biometry( ACD, AL, LT, K1, K2, WTW)
30 minutes per person
Study Arms (1)
one group compared two measurement methods
one group compared two measurement methods
Interventions
2 swept source OCT biometers, IOL Master700 and Anterion
Eligibility Criteria
participants from the glaucoma clinic at Rajavithi Hospital, Bangkok, Thailand. between May and December 2020
You may qualify if:
- phakic eye
- diagnosis of PACD, including primary angle-closure suspect (PACS), primary angle-closure (PAC) and primary angle-closure glaucoma (PACG) as classified by Foster et al
You may not qualify if:
- patients who had opaque optical media
- dense cataract
- anterior and/or posterior segment diseases such as advanced pterygium, diabetic retinopathy, or maculopathy
- Participants who had previous history of ocular trauma, ocular surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Somporn Chantra
Bangkok, 10400, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Somporn Chantra, MD
Department of Medical Services Ministry of Public Health of Thailand
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2021
First Posted
September 22, 2021
Study Start
May 1, 2020
Primary Completion
August 31, 2021
Study Completion
September 3, 2021
Last Updated
September 22, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share